| Name | Title | Contact Details |
|---|
NUCATS provides scientists with consultative resources and expertise in order to accelerate how quickly transformative scientific discoveries make their way to patients and the community. It is our goal to continually increase the quality, safety, efficiency and speed of innovative clinical and translational research.
Micro Invasive Technology is a Pomfret Center, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
New Chapter Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
Vertebral Technologies is a Minnetonka, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.